AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 2 filers reported holding AUDENTES THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $11,179,000 | +122.9% | 186,823 | +4.6% | 0.00% | +200.0% |
| Q3 2019 | $5,015,000 | -20.4% | 178,549 | +7.3% | 0.00% | -50.0% |
| Q2 2019 | $6,302,000 | +1.6% | 166,441 | +4.7% | 0.00% | 0.0% |
| Q1 2019 | $6,202,000 | +91.1% | 158,933 | +4.4% | 0.00% | +100.0% |
| Q4 2018 | $3,245,000 | -35.9% | 152,232 | +19.1% | 0.00% | 0.0% |
| Q3 2018 | $5,059,000 | +3.7% | 127,770 | +0.1% | 0.00% | 0.0% |
| Q2 2018 | $4,879,000 | +68.1% | 127,693 | +32.1% | 0.00% | 0.0% |
| Q1 2018 | $2,903,000 | +12.7% | 96,645 | +17.3% | 0.00% | 0.0% |
| Q4 2017 | $2,575,000 | +68.0% | 82,409 | +50.6% | 0.00% | – |
| Q3 2017 | $1,533,000 | +51.5% | 54,722 | +3.4% | 0.00% | – |
| Q2 2017 | $1,012,000 | +215.3% | 52,900 | +180.7% | 0.00% | – |
| Q1 2017 | $321,000 | +26.9% | 18,843 | +36.2% | 0.00% | – |
| Q4 2016 | $253,000 | – | 13,834 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 1,204,615 | $36,198,681,000 | 11.58% |
| Sofinnova Investments, Inc. | 1,380,303 | $41,478,000 | 7.13% |
| Casdin Capital, LLC | 450,000 | $13,523,000 | 2.38% |
| Foresite Capital Management III, LLC | 315,331 | $9,476,000 | 2.06% |
| Opaleye Management Inc. | 190,000 | $5,709,000 | 1.63% |
| Redmile Group, LLC | 1,308,526 | $39,321,000 | 1.52% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,384,470 | $41,603,000 | 1.44% |
| Orbimed Advisors | 3,522,100 | $105,839,000 | 1.31% |
| Rock Springs Capital Management LP | 565,000 | $16,978,000 | 0.72% |
| Cormorant Asset Management, LP | 322,945 | $9,704,000 | 0.72% |